Peer Review History
| Original SubmissionJune 13, 2022 |
|---|
|
PONE-D-22-15349Fatty acid binding protein 1 and fatty acid synthetase overexpression have differential effects on collagen III and cross-linking in Zongdihua pig tissuesPLOS ONE Dear Dr. Zhou, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by August 29. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marcio Duarte, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.
In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ. Additional Editor Comments: Please double check the statistical analysis description. In your revision, make sure to describe in detail what analysis were performed. Also, please include in the revised manuscript the equation of your experimental model for better clarification of what were the effects considered on statistical analysis. The lack of the detail description in statistical analysis may result in the rejection of the manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: I Don't Know Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Title: Fatty acid binding protein 1 and fatty acid synthetase overexpression have differential effects on collagen III and cross-linking in Zongdihua pig tissues The current manuscript reports the initial basis on how the overexpression of FABP1 and FAS influence fat accumulation in adipocytes and in the expression of COL3A1 and LOX. The results may serve to other more complexes studies, and these future perspectives should have been reported. Moreover, an additional attention should be given to the manuscript before submission to avoid typos and the inclusion of incorrect references. In summary, my concerns are a) It was not reported the number of animals used for tissue extraction; b) the lack of protein abundance analysis to evaluate the functionality of the evaluated genes (mainly FAS, FABP1, COL3A1); c) the lack of references supporting the presence of FABP isoform 1 in muscle and adipocytes. Please consider the comments below. Introduction -The first citation starts in 3. Please review the references and citations. -Why FABP1 was chosen to be evaluated instead of other known muscle/adipocyte FABPs isoforms? Previous studies have reported FABP1 as a predominant isoform in liver. If there is any evidence reporting FABP1 in muscle/adipocytes I suggest adding such information in introduction and/or discussion section. L42-43: change “that is synthesized in large amounts” to “extensively synthesized” L44- 47: change “reservoir of” to “storage of” L52-55: This paragraph needs to be improved and the aim of the study need to be consisting to what was evaluated. The current study does not provide sufficient molecular and genetic basis for such affirmation. Material and methods L58: Typo “Statement” L64: Please specify how many pigs were used in each age L65: Correct the name of pigs’ breed L68: “…, frozen in liquid nitrogen and stored at -80 °C to further analyses.” L69, L81: Please unify the information from those sections to its respective analysis L88: Which shaded areas? L102: Please cite the reference of this method L105: Subcutaneous fat cDNA from which pigs? 3d and 9m pigs? L109: Please specify here the name of the commercial kit L118: How many 3d old pigs were used? The previous analysis (genes expression) was done with 3d and 9m old pigs? Please provide an explanation about the use of 3 d old pigs for adipocytes culture instead of 9m old pigs. L145: Please specify here the name of the commercial kit Please avoid the use of “(see below)” and “(see above)” throughout the text. L148: the section 1.5 can be placed together with this section L153: Please add the statistical model in this section. L154: Please cite the method used to normalize mRNA L157: Why DNA sequencing was performed? Please specify and add the methods and steps of this analysis. Results L159: Please remove “analysis” from the section’s title L169-172: Please indicate what was the purpose of these analyses. Figure 4: Please verify figure’s letters L172-174: Please explain how this analysis was performed? L179-L181: Please correct the figure citation Figure 6: intramuscular or subcutaneous preadipocytes? L195: “…were constructed and fused to …” L199 and figure 7: what would be the blank control? please specify Fig 8: Please correct figure legend “..transfected with pEGFP-C1-FAS and pEGFP-C1-FAS as indicated..” L204 and Figure 8: Please specify what would be the control group. L208-209: Did you mean double-antibody sandwich ELISA method? Discussion L2017-218: Is there any other reference to cite this statement? I could not find reference number 13. Also, the “adipocyte-type fatty acid binding protein” in the title referees to A-FABP or FABP4 and not FABP1. L219-220: Reference number 14 did not evaluate FABP1 expression. L220-221: Is there any other reference to cite this statement? I could not find reference number 15. Please carefully revise the discussion section and if possible, change the references that are not written in English, so the reader can easily find in the future. L226-228: This is a strong affirmative that need to be rewritten. Since the current study did not evaluate the protein levels of FABP1 and FAS or used methods to inactive the function of these proteins, there is no assurance that FABP1 and FAS can be considered the only candidate genes to infer in fat accumulation. L228-230: The results of this analysis need to be shown and better explained, as well as the methodology. L232: Please cite the previous studies. L232: “....that COL3A1 and LOX…” L233: “…than longissimus dorsi muscle ...” L232-233: That is not what was reported in Figure 1, where the expression of all the genes were higher in subcutaneous fat compared to muscle. L234: Please add a reference to the statement. L236: What did you mean with “may damage”? Please provide better explanation L243: Typo “adipocytes” L244: Which gene products? What did you mean with “decomposition of fat”. Please be more objective L253: Add citation L262: Is there any refence reporting the meat quality parameter of Zongdihua pigs comparing with other breeds? If so, it could be included to support this hypothesis. Conclusions As previously mentioned, this affirmation should be excluded or reformulated. Moreover, a perspective of future studies could be included. Figures I suggest reporting Figures 2, 5, 6 , and 7 as supplementary. Reviewer #2: TITLE The title reflects the work's main result which means that instead of “Zongdihua pig tissues” you must use Zongdihua pig isolated adipocytes once the overexpression was done in isolated cells, not in tissue. ABSTRACT Line 19. Please, Replace Zongdihua pig by Zongdihua pig isolated adipocyte Line 19. Replace identify processes by identify biochemical processes Line 20. Replace, using molecular genetics by molecular tools INTRODUCTION Line 40. In the first paragraph, please, develop in a deeper way the signaling pathway crosslink between the genes FABP1, FAS, and COL3A1 Line 53. Please, in the sentence “In the present study… you should increment the paragraph with a clear objective of the study. Which question will be answered? MATERIAL AND METHODS Line 87. Please, add the Accession number (e.g NM_) of the sequences you have used to design oligonucleotides. Line 138. If you have used 4ug of plasmid to transfect, please add this information just before the sentence “recombinant plasmids pEGFP-C1-FABP1 and pEGFP-C1-FAS”. Otherwise, what is the 4ug of DNA? Add empty plasmids controls and blanks to sentence. Clarify this sentence until line 140. Line 153. In Data processing and analysis, The 2-△△Ct method is a gene expression method and I do not identify the statistical methods used not only in gene expression analysis, but also in the other analysis. Please, add the proper information and experimental design in this subtopic. RESULTS AND ANALYSIS Line 163. Please, delete the term “extremely” Line184. Delete the term “and differentiate” or changed it to “morphology differentiate” following the idea of the next sentence. Line 191. Don’t you have the quantification the lipids content staining with Oil Red O as you mentioned in MM? Put the data in figure 6 and refer to it here. Line 195. Please, the sentence “Cloned versions of FAS and FABP1 were constructed that were fused to the eGFP protein at their carboxyl termini and over-expressed via the strong CMV promoter” is important to MM section. Relocate it. Otherwise, just here the reader will understand what was done. DISCUSSION It was well developed CONCLUSION It was well developed FIGURES Figures 1 and 8. Please, in the Y axis add “/GAPDH” just after relative expression. Figures 5 and 6. Please, add magnification bar in the bottom corner of the image. Images seems in different magnification. Figure 6. Please, add E image of graphical representation of the Oil red O staining quantification as you mentioned on MM. Figure 7. Here we have some problems. This figure per se is not a result, but only a control of the efficiency of you transfection. I strongly recommend you to put together this figure to figure 8. In addition, I think we have a problem with the image once only pEGFP-C1-FAS transfected cell have been shown (doubled data). The magnification of the images seems different, please, correct that. Reviewer #3: Dear authors, The manuscript entitled “Fatty acid binding protein 1 and fatty acid synthetase overexpression have differential effects on collagen III and cross-linking in Zongdihua pig tissues” aims to determine whether FABP1 and FAS regulate expression of collagen and its crosslinking via lysyl oxidase in Zongdihua pigs. The manuscript points out that enhancing the expression of FAS and FABP1 increases collagen accumulation and this preliminarily suggests that FAS and FABP1 can serve as fat-related candidate genes providing a theoretical basis for the study of fat deposition in Zongdihua pigs. The manuscript brings interesting results, however, to be accepted for publication, it needs major changes and corrections. Below are suggestions to make the manuscript suitable for publication and more informative to the reader. General suggestions - Write all gene names in italics. Example: FABP1 - Please review the text for language. - Some words are used in different ways in the manuscript such as cross-linking/crosslinking, Over-expression/Overexpression…Correct this, please. - The introduction needs to be rewritten, addressing the issues related to the manuscript more deeply. In addition, give a clear hypothesis and objective in the introduction section. - Please, change “longissimus dorsi” to “Longissimus dorsi” throughout the manuscript. - Discussion needs to be rewritten, addressing more deeply the observed results. Abstract - Line 26 - Remove the with in the sentence "FAS encodes 333 amino acid hydrophobic protein containing with 26 phosphorylation sites and 0 transmembrane regions". - Line 27 - Change the following sentence "The basal levels of FABP1 and FAS in pig tissues expression were 3 -3.5-fold higher in subcutaneous fat compared with muscle (P < 0.01)" to "The basal levels of FABP1 and FAS expression in pig tissues were 3 -3.5-fold higher in subcutaneous fat compared with muscle (P < 0.01)". - Line 33- I believe you forgot to add “FAS” in this sentence "Therefore, enhancing FABP1 expression increases collagen accumulation...". Am I correct? Because the overexpression of FAS and FABP1 resulted in a significantly increased expression of the COL3A1 gene. - Keywords must be arranged in alphabetical order. It is not recommended to add words that are already in the title of the manuscript such as Zongdihua pig. Introduction - Add the title “Introduction” before the text in the line 40. - You could improve your introduction by talking more about the breed (Zongdihua pig), mainly about the meat traits. It could also present some preliminary studies that address the evaluated genes deeply. All these issues need to be better integrated. In addition, the objective of the work should be better presented in this introduction. Materials and methods - Line 58 - Correct to Ethics Statements. - Why is the topic "Ethics Statements" highlighted in the text? - Please, I ask you to correct the text in relation to the language used. Some sentences are poorly worded. - You don't write about the design and accession number of the following genes: LOX and COL3A1 in the text. - Did you work with the fold change (comparative CT method)? Why are the graphs with the Y-axis legend as a relative expression? I suggest reading the article "Analyzing real-time PCR data by the comparative CT method - Thomas D Schmittgen1 & Kenneth J Livak 2008" to correct this question. - Subcutaneous fat and Longissimus dorsi samples were collected from how many animals? What is the N of this gene expression analysis? You need to better describe the experimental design of the study. Results - Why in the legend of figure 1 you used fat deposition if there is only information about the fold change between subcutaneous fat and Longissimus dorsi? - Line 163:164 – “The expression levels for all 4 genes were extremely significantly (P < 0.01) elevated in subcutaneous fat tissues compared with the muscle (control) tissues (Figure 1).” Why did you compare subcutaneous fat to muscle? Your hypothesis should be very clear in the manuscript in relation to the comparisons made. Besides that, could you explain a little more about what you considered as a control in this study? - Is the Y-axis legend correct in Figure 9? Discussion - Line 225:226 – Change the sentence “In this study, we found that FABP1 and FAS gene expression were significantly higher than for the control muscle tissue” to “In this study, we found that FABP1 and FAS gene expression were significantly higher in subcutaneous fat than for the control muscle tissue” - Line 232 – Alter LOC gene to LOX. - Your discussion of the results is superficial, you need to go deeper into the effect of the FAS and FABP1 genes on the expression of COL3A1 and LOX and the production of collagen. In addition to the effects of these genes on the deposition of fat and on meat traits. - Line 231:233- “Our results agreed with previous studies indicating that COL3A1 and LOC gene expression in subcutaneous fat are significantly higher and lower than in longissimus dorsi muscle tissues, respectively.” - Figure 1 shows greater expression of both the COL3A1 and LOX genes in subcutaneous fat in relation to Longissimus dorsi. - You have not discussed deeply the effects of the expression of these genes on meat quality in the breed studied. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Da Silva, Walmir Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-22-15349R1Fatty acid binding protein 1 and fatty acid synthetase over-expression have differential effects on collagen III synthesis and cross-linking in Zongdihua pig primary adipocytesPLOS ONE Dear Dr. Zhou, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 01 2022 11:59PM If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marcio Duarte, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Title: Fatty acid binding protein 1 and fatty acid synthetase over-expression have differential effects on collagen III synthesis and cross-linking in Zongdihua pig primary adipocytes I have noticed some changes in the current manuscript version, however, some suggestions and questions were answered but not addressed in the manuscript. The general introduction and discussion need to be restructured to provide a better link between the paragraphs and a better understanding of the reader. Please consider the suggestions bellow: Abstract L30-31: “We aimed…” L32: breeding improvement in terms of what? L37: Please remove “FAS encodes …….regions.” Introduction L52- 70: These two paragraphs need extensive revision mainly in term of sentence structure. For example, L52-55 can be transformed into 3 sentences “The extracellular matrix (ECM) play roles in adipocyte proliferation, differentiation, and migration. Moreover, ECM anchors these cells to prevent mechanical movement and protect mature adipocytes from external compression and stimulation. It is well established that collagen is the main component of ECM ….” L81-85 This paragraph is disconnected from the rest of the text, please reorganize the introduction section. I would suggest to focus and organize this section by following the topics: Breed and meat characteristics, ECM and its components, FABP1 and it regulatory role, and a clear description of the objectives (The present study aimed to investigate x, y and z …) Material and Methods L95: “Healthy Zongdihua pigs including …” -Section 1.3 (Reagents) and 1.4 (primer design and synthesis): the information in these sections should be placed with its respective analyses and these topics removed, as I have already mentioned in the first revision. - The accession numbers described in section 1.4 could be better visualized if placed in a column of Table 1. L125: The total RNA was extracted from fat and longissimus dorsi muscle from pigs in which age? 3d , 9 mo or both? Since you have collected tissue from both ages and in some analysis you used only one age, make sure you are being specific throughout the manuscript. L155: by DNA sequencing? How was done the bioinformatic analysis of DNA sequencing data? Please add a description or reference of the employed methodology. L187: It is not clear what was considered in the statistical model, fixed and random effects. All the information needs to be clear to allow reproducibility. Results L192: “2 Results” L193: “2.1 Differential expression analysis” L164: please specify the age of the pigs in text and Figures. L236: “… were examined for lysyl …” L239-240: “(Figure 5B)” Discussion L260-261: This is a strong affirmation. Since you compared two different cell lines (from muscle vs adipose tissue), it is expected, and already reported, greater influence of this genes on adipocytes compared to muscle. To ensure that these genes are associated with greater fat deposition ability you should have evaluated pigs with different levels of subcutaneous fat, different breeds, etc. Please rewrite the indicative of this data or provide references of the influence of these genes on greater subcutaneous fat deposition. L274-277: repeated sentences. Similar to introduction, the paragraphs seem disconnected. Please improve the link between paragraphs for better understanding and clarity. Conclusion: ok Figure 3. Please verify the letters. Figure 4 “…. COL3A1..” ; transfected with (A) pEGFP-C1-FAS and (B) pEGFP-C1-FAS? Please correct figure’s legend. Reviewer #2: Dear Authors, Thank you to considering most of questions raised previously to make the manuscript suitable for publication and more informative to the reader. Most of concerns were properly addressed, but I still have some serius concerns about the Statistics. To make the data more informative, at the Data processing topic, 2^-ddCt is a method to access the fold relative gene expression. In order the access the differences in gene expression between the groups you must use a proper statistical model and test (parametric or non-parametric) and I still have not seen it in the text. Please, it is important to add not only the software, but also the test you have used. In addition, please add a supplementary table at the supplementary material with cT collected data from qPCR for each replicate, dissociation curves for each gene reaction and the statistical metrics. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-22-15349R2Fatty acid binding protein 1 and fatty acid synthetase over-expression have differential effects on collagen III synthesis and cross-linking in Zongdihua pig primary adipocytesPLOS ONE Dear Dr. Zhou, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by March 10. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marcio Duarte, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The answers were addressed, and I could realize an improvement throughout the text. However, it still need some minor revision, mainly regarding the clarity in some sentences to make the paper more objective to the reader. Please consider the comments below. Abstract: ok Introduction L48-49: “…fibrillar collagens and the expression….” L55: “…such as TGF-β, which is a positive…” L56: “…collagen genes and it is highly…” L71-85: I suggest to remove this paragraph Material and Methods L95-96: not necessary to report “( conform to the characteristics of this breed, have good growth performance and have no diseases)”. I suggest to remove L135: “…proteins were analyzed…” L144: Please remove “as per above” here and throughout the text L145: “The fat cell of 3-day-old pigs were cultured and the pellets were suspended…” L162: please correct “37oC” Results L201: Please verify the Figure’s citation here and throughout the text L224: Figure 4 shows the P < 0.01 for COL3A1 expression in both over-expressed clones. Please correct this information here or in the Figure L226-227: Please correct this sentence for “We further examined the effects of transfected plasmids on LOX mRNA levels and lysyl oxidase activity.” L229: “..double-antibody sandwich ELISA method…” Discussion L253-256: Please substitute the sentence to: “The expression level of subcutaneous adipose tissue in Kele pig and DLY crossbred pig is significantly higher than longissimus dorsi muscle” and add a citation. L256-258: Please substitute the sentence to: “Moreover, the expression level of subcutaneous adipose FABP1 in the Kele pig is higher than DLY crossbred pig, which may be due to the fact that the Kele pig is a local pig that present a high fat deposition” and add a citation. L259: “…significantly higher compared to longissimus dorsi muscle…” L260: “These data may indicate that FABP1….” L263: which studies? Please cite L264: “significantly higher compared to longissimus dorsi muscle. The results…” L265: “….compared to muscle” L265-267: The expression of LOX is lower in fat compared to muscle or the expression of LOX is lower in muscle compared to fat?? This sentence is confused. Please rephrase this sentence and cite the paper. L267-270: I suggest to substitute by “By culturing primary adipocyte from subcutaneous fat we were able to successfully over-express FAS and FABP1 in Zongdihua pig preadipocytes and this resulted in increased COL3A1 and decreased LOX expression levels (P<0.01) as well as lysyl oxidase activities” L277: “…gene products collectively affected…” L290: “…while inhibited LOX…” Conclusion: COL3A1 is in italic, but the other genes are not, please follow a pattern throughout the text. I suggest reporting mRNAS in italic. Supplementary material: Table S1, S2 and S3: Unnecessary to report. I suggest to remove. Figure S5 should be cited in the text Reviewer #2: Dear author, I got your point and the comparative dct method seems correct, but I still have some serious concerns about the statistics you should have done after that. At the Data processing and statistical topic, 2^-ddCt is a method to access the fold relative gene expression, which means that using this mathematical model you are able to compare different groups in terms of gene expression level e.g. how many times a gene is more expressed in one group than another. In another hand, in order to access if there is a statistical difference between groups you must use a proper statistical model/test (parametric or non-parametric) after ddct method; and I still have not seen it in the text. A one-way ANOVA or t-test would be enough for you. Once the statistical metrics have not been properly addressed I can not trust any qPCR results. I strongly suggest you to perform the statistical test and potential corrections and resubmit the manuscript. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Fatty acid binding protein 1 and fatty acid synthetase over-expression have differential effects on collagen III synthesis and cross-linking in Zongdihua pig primary adipocytes PONE-D-22-15349R3 Dear Dr. Zhou, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Marcio Duarte, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): All comments made in the last revision were adequately addressed. The manuscript is ready for publication. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-15349R3 Fatty acid binding protein 1 and fatty acid synthetase over-expression have differential effects on collagen III synthesis and cross-linking in Zongdihua pig primary adipocytes Dear Dr. Zhou: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Marcio Duarte Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .